Title : Gemcitabine/Cisplatin Treatment Induces Concomitant SERTAD1, CDKN2B and GADD45A Modulation and Cellular Changes in Bladder Cancer Cells Regardless of the Site of TP53 Mutation.

Pub. Date : 2018 Apr

PMID : 28577130






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Gemcitabine/Cisplatin Treatment Induces Concomitant SERTAD1, CDKN2B and GADD45A Modulation and Cellular Changes in Bladder Cancer Cells Regardless of the Site of TP53 Mutation. gemcitabine tumor protein p53 Homo sapiens